Results 91 to 100 of about 11,899,379 (393)

MicroRNA Biomarkers for Infectious Diseases: From Basic Research to Biosensing

open access: yesFrontiers in Microbiology, 2020
In the pursuit of improved diagnostic tests for infectious diseases, several classes of molecules have been scrutinized as prospective biomarkers. Small (18–22 nucleotide), non-coding RNA transcripts called microRNAs (miRNAs) have emerged as promising ...
L. Tribolet   +6 more
semanticscholar   +1 more source

Molecular characterisation of human penile carcinoma and generation of paired epithelial primary cell lines

open access: yesMolecular Oncology, EarlyView.
Generation of two normal and tumour (cancerous) paired human cell lines using an established tissue culture technique and their characterisation is described. Cell lines were characterised at cellular, protein, chromosome and gene expression levels and for HPV status.
Simon Broad   +12 more
wiley   +1 more source

European Code Against Cancer, 5th edition – hormone replacement therapy, other common medical therapies and cancer

open access: yesMolecular Oncology, EarlyView.
The 5th edition of the European Code Against Cancer (ECAC5) contains 14 recommendations on cancer prevention. Here, we update the cancer prevention recommendations regarding the use of hormone replacement therapy (HRT), which is positioned as recommendation number 13 of the ECAC5.
Mangesh A. Thorat   +18 more
wiley   +1 more source

Current status of herbal and their future perspectives [PDF]

open access: yes, 2007
Traditional medicine is the synthesis of therapeutic experience of generations of practicing physicians of indigenous systems of medicine. Throughout the history of mankind, many infectious diseases have been treated with herbals.
Ponnampalam Gopalakrishnakone   +1 more
core   +1 more source

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

open access: yesMolecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg   +43 more
wiley   +1 more source

Spread of infectious diseases: Effects of the treatment of population

open access: yes, 2017
In a metapopulation network, infectious diseases spread widely because of the travel of individuals. In the present study, we consider a modified metapopulation Susceptible-Infected-Removed (SIR) model with a latent period, which we call the SHIR model ...
Kudo, Kazue, Mizuno, Kanako
core   +1 more source

Protein O‐glycosylation in the Bacteroidota phylum

open access: yesFEBS Open Bio, EarlyView.
Species of the Bacteroidota phylum exhibit a unique O‐glycosylation system. It modifies noncytoplasmic proteins on a specific amino acid motif with a shared glycan core but a species‐specific outer glycan. A locus of multiple glycosyltransferases responsible for the synthesis of the outer glycan has been identified.
Lonneke Hoffmanns   +2 more
wiley   +1 more source

Emerging infectious diseases and insensible bacillus infectious diseases. Emerging infectious diseases. O157 infectious disease.

open access: yesNihon Naika Gakkai Zasshi, 1997
1996年夏に多発した腸管出血性大腸菌O157感染症は医学的,細菌学的のみならず社会的な問題ともなった.本年になっても多くの集団例,散発例が報告され,けっして我々のまわりからO157の危険が去ったわけではない. O157感染症の大きな問題点はその病態が単なる食中毒のような腸管感染症にとどまらず, HUSや脳症のような重篤な合併症を併発し全身性感染症的要素を有すること,また合併症に対する有効な治療法が確立していないことである.
openaire   +2 more sources

The Dynamics of Real-Time Online Information and Disease Progression: Understanding Spatial Heterogeneity in the Relationship [PDF]

open access: yes, 2019
The re-emergence of infectious diseases such as measles and polio is creating logistics challenges for the state authorities to curb their spread and contain them.
Chen, Kuanchin   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy